Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-11-11 00:55 |
Immediate Report of Meeting to be held on December 22,2021,proxy
|
English | 164.1 KB | ||
| 2021-11-11 00:53 |
Annual General Meeting of Shareholders to be held on December 22,2021,proxy sta…
|
English | 281.7 KB | ||
| 2021-11-11 00:53 |
Annual General Meeting of Shareholders to be held on December 22,2021,proxy sta…
|
English | 36.6 KB | ||
| 2021-11-10 18:44 |
6K Amended Report -Termination of Material Agreement- include incorporation by …
|
English | 150.1 KB | ||
| 2021-11-10 18:44 |
6K Amended Report -Termination of Material Agreement- include incorporation by …
|
English | 35.8 KB | ||
| 2021-11-04 15:40 |
6K: Financial results for the three-month period ended September 30, 2021
|
English | 173.8 KB | ||
| 2021-11-04 15:40 |
6K: Financial results for the three-month period ended September 30, 2021
|
English | 36.5 KB | ||
| 2021-10-26 17:37 |
6K:Purple Biotech Expands Research
Collaboration in Immuno-Oncology in Combinat…
|
English | 170.9 KB | ||
| 2021-10-26 17:37 |
6K:Purple Biotech Expands Research
Collaboration in Immuno-Oncology in Combinat…
|
English | 36.4 KB | ||
| 2021-10-23 23:11 |
Publication in Nature Cancer Demonstrating Mechanisms Behind Cancer Cell Persis…
|
English | 173.8 KB | ||
| 2021-10-23 23:11 |
Publication in Nature Cancer Demonstrating Mechanisms Behind Cancer Cell Persis…
|
English | 36.5 KB | ||
| 2021-10-14 15:44 |
settlement agreement with Lupin
|
English | 123.4 KB | ||
| 2021-10-14 15:44 |
settlement agreement with Lupin
|
English | 36.2 KB | ||
| 2021-10-10 02:36 |
6K:Termination of distribution agreement with Coeptis
regarding the distributi…
|
English | 122.7 KB | ||
| 2021-10-10 02:36 |
6K:Termination of distribution agreement with Coeptis
regarding the distributi…
|
English | 36.2 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
